BD (Becton, Dickinson and Company) has announced the acquisition of Tepha, Inc., a leading developer and manufacturer of a proprietary resorbable polymer technology, based in the US.

Tepha's proprietary resorbable polymer (Poly 4-hydroxybutyric acid, P4HB) technology platform provides additional innovation potential that can accelerate the growth of BD's surgical mesh portfolio and drives the company into potential new areas within soft tissue repair, reconstruction and regeneration.

The acquisition of Tepha also provides strategic vertical integration of an important supply chain component for BD's existing Phasix™ Mesh products. Tepha's GalaFLEX^® portfolio, also based on the novel P4HB polymer, is included in the acquisition. 

Tepha's GalaFLEX^® products are a bioresorbable scaffold for soft tissue support and to repair, elevate and reinforce deficiencies where weakness or voids exist that require the addition of material to obtain the desired surgical outcome.